nov 2017 hepatitis c gt3a lipid HCV Replicon Systems: Workhorses of Drug Discovery and Resistance Highly replicating hepatitis C virus
Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease Nature Communications Synthetic approaches and application of clinically approved small molecule drugs to treat hepatitis ScienceDirect Hepatitis C: The Story of a Long Journey through First, Second, and Third Generation NS3 4A Peptidomimetic Inhibitors. What Did We Learn? Journal of Medicinal Chemistry An Antigenically Diverse, Representative Panel of Envelope Glycoproteins for Hepatitis C Virus Vaccine Development Gastroenterology Recruitment and Activation of a Lipid Kinase by Hepatitis C Virus NS5A Is Essential for Integrity of the Membranous Replication Compartment ScienceDirect
Pay in 4 interest-free payments of $6.62 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




